Filed by the Registrant | | | ☒ | | | |
Filed by a Party other than the Registrant | | | ☐ | | |
☐ | | | Preliminary Proxy Statement |
☐ | | | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☒ | | | Definitive Proxy Statement |
☐ | | | Definitive Additional Materials |
☐ | | | Soliciting Material Pursuant to § 240.14a-12 |
Rani Therapeutics Holdings, Inc. | | ||
(Name of Registrant as Specified In Its Charter) | | ||
| |||
(Name of Person(s) Filing Proxy Statement if other than the Registrant) |
☒ | | | No fee required. |
☐ | | | Fee paid previously with preliminary materials |
☐ | | | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |